Jing et al. showed that miR-21 could be transferred from gefitinib-resistant lung cancer cells (H827R) to gefitinib-sensitive (HCC827) via exosomes and thus induce gefitinib resistance in sensitive lung cancer cells through AKT activation [57]. Here, AKT1 is linked to lung cancer.